Table 5:
How should germline risk assessment be performed?*
Consensus question | Yes | No |
---|---|---|
| ||
Can physicians (urologists/oncologist) with expertise in hereditary kidney cancer syndromes offerpre-test counseling in patients suspected of having hereditary kidney cancer? | 92% | 8% |
| ||
Is a standardized video covering essential elements of counseling sufficient for pre-test counseling in individuals suspected of having hereditary kidney cancer? | 59% | 41% |
| ||
Should germline testing in patients who did not have any pre-test counseling be performed? | 0% | 100% |
| ||
If an individualizedpre-test counseling was not performed, but germline testing is pursed, testing should: | ||
a) include a comprehensive cancer gene panel to avoid testing too narrowly | 8% | |
b) include a kidney specific gene panel only to keep focused | 92% | |
| ||
Is a telehealth/telegenetics visit with a licensed counselor sufficient for evaluation of individuals suspected of having hereditary kidney cancer? | 93% | 7% |
| ||
Should individuals with variants of unknown significance (VUS) in genes that could explain a hereditary kidney cancer phenotype be treated as affected until more information if obtained? | 56% | 44% |
Statements in bold represent those with reached consensus